论文部分内容阅读
目的:探讨生长抑素对ERCP术后胰腺炎的预防效果。方法:选取巴彦淖尔市医院2014年4月~2016年3月进行ERCP手术的患者52例作为研究对象,分为对照组(n=26)和观察组(n=26)。两组患者术前用药一致,术中对照组予以常规治疗,观察组予以生长抑素。观察两组患者ERCP手术前后血清淀粉酶含量及术后并发情况。结果:手术前,两组患者血清淀粉酶含量比较,差异无统计学意义(P>0.05),治疗3h及24h后,观察组血清淀粉酶含量均明显低于对照组,差异具有统计学意义(P<0.05);观察组和对照组胰腺炎发生率差异具有统计学意义(P<0.05)。结论:生长抑素对ERCP术后胰腺炎预防效果良好。
Objective: To investigate the preventive effect of somatostatin on post-ERCP pancreatitis. Methods: 52 patients who underwent ERCP in Bayannur Hospital from April 2014 to March 2016 were selected as the control group (n = 26) and observation group (n = 26). The two groups of patients preoperative medication consistent intraoperative control group, the observation group was somatostatin. Serum amylase levels and postoperative complications were observed before and after ERCP in the two groups. Results: Before operation, there was no significant difference in serum amylase between the two groups (P> 0.05). After 3 and 24 hours of treatment, the serum amylase content of the observation group was significantly lower than that of the control group (P <0.05) P <0.05). There was significant difference in the incidence of pancreatitis between the observation group and the control group (P <0.05). Conclusion: Somatostatin has a good preventive effect on post-ERCP pancreatitis.